nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—Fluorouracil—urinary bladder cancer	0.0481	0.262	CbGbCtD
Rufinamide—CYP3A4—Thiotepa—urinary bladder cancer	0.0464	0.253	CbGbCtD
Rufinamide—CYP2E1—Etoposide—urinary bladder cancer	0.0415	0.226	CbGbCtD
Rufinamide—ALB—Methotrexate—urinary bladder cancer	0.0265	0.144	CbGbCtD
Rufinamide—CYP3A4—Etoposide—urinary bladder cancer	0.0126	0.0685	CbGbCtD
Rufinamide—SCN7A—prostate gland—urinary bladder cancer	0.0121	0.0896	CbGeAlD
Rufinamide—GRM5—female reproductive system—urinary bladder cancer	0.0105	0.0775	CbGeAlD
Rufinamide—SCN9A—prostate gland—urinary bladder cancer	0.00951	0.0702	CbGeAlD
Rufinamide—CYP2E1—urine—urinary bladder cancer	0.00868	0.064	CbGeAlD
Rufinamide—CYP3A4—Doxorubicin—urinary bladder cancer	0.00858	0.0467	CbGbCtD
Rufinamide—SCN4A—prostate gland—urinary bladder cancer	0.00848	0.0626	CbGeAlD
Rufinamide—CES1—prostate gland—urinary bladder cancer	0.00758	0.0559	CbGeAlD
Rufinamide—CYP3A4—urine—urinary bladder cancer	0.00699	0.0515	CbGeAlD
Rufinamide—SCN7A—female reproductive system—urinary bladder cancer	0.00663	0.0489	CbGeAlD
Rufinamide—SCN3A—prostate gland—urinary bladder cancer	0.0066	0.0487	CbGeAlD
Rufinamide—SCN4A—renal system—urinary bladder cancer	0.00578	0.0427	CbGeAlD
Rufinamide—SCN3A—renal system—urinary bladder cancer	0.0045	0.0332	CbGeAlD
Rufinamide—CES1—female reproductive system—urinary bladder cancer	0.00414	0.0305	CbGeAlD
Rufinamide—SCN7A—lymph node—urinary bladder cancer	0.00388	0.0286	CbGeAlD
Rufinamide—SCN2A—vagina—urinary bladder cancer	0.00371	0.0274	CbGeAlD
Rufinamide—SCN3A—female reproductive system—urinary bladder cancer	0.0036	0.0266	CbGeAlD
Rufinamide—SCN3A—vagina—urinary bladder cancer	0.00326	0.024	CbGeAlD
Rufinamide—SCN5A—vagina—urinary bladder cancer	0.00325	0.024	CbGeAlD
Rufinamide—CYP2E1—prostate gland—urinary bladder cancer	0.00312	0.023	CbGeAlD
Rufinamide—SCN9A—lymph node—urinary bladder cancer	0.00304	0.0224	CbGeAlD
Rufinamide—CYP2E1—seminal vesicle—urinary bladder cancer	0.00264	0.0194	CbGeAlD
Rufinamide—CES1—lymph node—urinary bladder cancer	0.00242	0.0179	CbGeAlD
Rufinamide—SCN10A—lymph node—urinary bladder cancer	0.00231	0.0171	CbGeAlD
Rufinamide—CYP2E1—renal system—urinary bladder cancer	0.00212	0.0157	CbGeAlD
Rufinamide—SCN3A—lymph node—urinary bladder cancer	0.00211	0.0155	CbGeAlD
Rufinamide—CYP2E1—urethra—urinary bladder cancer	0.00209	0.0154	CbGeAlD
Rufinamide—CYP3A4—renal system—urinary bladder cancer	0.00171	0.0126	CbGeAlD
Rufinamide—CYP2E1—female reproductive system—urinary bladder cancer	0.0017	0.0126	CbGeAlD
Rufinamide—ALB—lymph node—urinary bladder cancer	0.00168	0.0124	CbGeAlD
Rufinamide—CYP3A4—female reproductive system—urinary bladder cancer	0.00137	0.0101	CbGeAlD
Rufinamide—Convulsion—Cisplatin—urinary bladder cancer	0.00107	0.00233	CcSEcCtD
Rufinamide—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00106	0.00231	CcSEcCtD
Rufinamide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00106	0.00231	CcSEcCtD
Rufinamide—Ataxia—Methotrexate—urinary bladder cancer	0.00106	0.00231	CcSEcCtD
Rufinamide—Infection—Fluorouracil—urinary bladder cancer	0.00105	0.0023	CcSEcCtD
Rufinamide—Diplopia—Epirubicin—urinary bladder cancer	0.00105	0.0023	CcSEcCtD
Rufinamide—Skin disorder—Gemcitabine—urinary bladder cancer	0.00105	0.00229	CcSEcCtD
Rufinamide—Anxiety—Cisplatin—urinary bladder cancer	0.00105	0.00229	CcSEcCtD
Rufinamide—Anaemia—Etoposide—urinary bladder cancer	0.00104	0.00228	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00104	0.00228	CcSEcCtD
Rufinamide—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00104	0.00227	CcSEcCtD
Rufinamide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00104	0.00227	CcSEcCtD
Rufinamide—Increased appetite—Doxorubicin—urinary bladder cancer	0.00104	0.00226	CcSEcCtD
Rufinamide—Anorexia—Gemcitabine—urinary bladder cancer	0.00103	0.00225	CcSEcCtD
Rufinamide—Breast disorder—Methotrexate—urinary bladder cancer	0.00101	0.00222	CcSEcCtD
Rufinamide—Vertigo—Etoposide—urinary bladder cancer	0.00101	0.00222	CcSEcCtD
Rufinamide—Anorexia—Fluorouracil—urinary bladder cancer	0.00101	0.00221	CcSEcCtD
Rufinamide—Leukopenia—Etoposide—urinary bladder cancer	0.00101	0.00221	CcSEcCtD
Rufinamide—Infection—Cisplatin—urinary bladder cancer	0.000999	0.00218	CcSEcCtD
Rufinamide—Ataxia—Epirubicin—urinary bladder cancer	0.000988	0.00216	CcSEcCtD
Rufinamide—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000986	0.00216	CcSEcCtD
Rufinamide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000985	0.00215	CcSEcCtD
Rufinamide—Convulsion—Etoposide—urinary bladder cancer	0.000978	0.00214	CcSEcCtD
Rufinamide—Skin disorder—Cisplatin—urinary bladder cancer	0.000977	0.00214	CcSEcCtD
Rufinamide—Insomnia—Gemcitabine—urinary bladder cancer	0.000976	0.00213	CcSEcCtD
Rufinamide—Diplopia—Doxorubicin—urinary bladder cancer	0.000972	0.00213	CcSEcCtD
Rufinamide—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00096	0.0021	CcSEcCtD
Rufinamide—Insomnia—Fluorouracil—urinary bladder cancer	0.00096	0.0021	CcSEcCtD
Rufinamide—Somnolence—Gemcitabine—urinary bladder cancer	0.000959	0.0021	CcSEcCtD
Rufinamide—Anorexia—Cisplatin—urinary bladder cancer	0.000959	0.0021	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000955	0.00209	CcSEcCtD
Rufinamide—Breast disorder—Epirubicin—urinary bladder cancer	0.00095	0.00208	CcSEcCtD
Rufinamide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000945	0.00207	CcSEcCtD
Rufinamide—Somnolence—Fluorouracil—urinary bladder cancer	0.000943	0.00206	CcSEcCtD
Rufinamide—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00094	0.00205	CcSEcCtD
Rufinamide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000938	0.00205	CcSEcCtD
Rufinamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000934	0.00204	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000932	0.00204	CcSEcCtD
Rufinamide—Fatigue—Gemcitabine—urinary bladder cancer	0.00093	0.00203	CcSEcCtD
Rufinamide—Constipation—Gemcitabine—urinary bladder cancer	0.000923	0.00202	CcSEcCtD
Rufinamide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000922	0.00202	CcSEcCtD
Rufinamide—Asthenia—Thiotepa—urinary bladder cancer	0.00092	0.00201	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000916	0.002	CcSEcCtD
Rufinamide—Infection—Etoposide—urinary bladder cancer	0.000916	0.002	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—urinary bladder cancer	0.000914	0.002	CcSEcCtD
Rufinamide—Influenza—Epirubicin—urinary bladder cancer	0.000908	0.00199	CcSEcCtD
Rufinamide—Neutropenia—Methotrexate—urinary bladder cancer	0.000908	0.00198	CcSEcCtD
Rufinamide—Dysuria—Methotrexate—urinary bladder cancer	0.000908	0.00198	CcSEcCtD
Rufinamide—Pruritus—Thiotepa—urinary bladder cancer	0.000908	0.00198	CcSEcCtD
Rufinamide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000902	0.00197	CcSEcCtD
Rufinamide—Skin disorder—Etoposide—urinary bladder cancer	0.000895	0.00196	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000888	0.00194	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—urinary bladder cancer	0.000879	0.00192	CcSEcCtD
Rufinamide—Anorexia—Etoposide—urinary bladder cancer	0.000878	0.00192	CcSEcCtD
Rufinamide—Diarrhoea—Thiotepa—urinary bladder cancer	0.000878	0.00192	CcSEcCtD
Rufinamide—Decreased appetite—Cisplatin—urinary bladder cancer	0.000874	0.00191	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—urinary bladder cancer	0.000874	0.00191	CcSEcCtD
Rufinamide—Pneumonia—Methotrexate—urinary bladder cancer	0.00087	0.0019	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00087	0.0019	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000868	0.0019	CcSEcCtD
Rufinamide—Infestation—Methotrexate—urinary bladder cancer	0.000865	0.00189	CcSEcCtD
Rufinamide—Infestation NOS—Methotrexate—urinary bladder cancer	0.000865	0.00189	CcSEcCtD
Rufinamide—Neutropenia—Epirubicin—urinary bladder cancer	0.000849	0.00186	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—urinary bladder cancer	0.000849	0.00186	CcSEcCtD
Rufinamide—Dizziness—Thiotepa—urinary bladder cancer	0.000848	0.00185	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—urinary bladder cancer	0.00084	0.00184	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—urinary bladder cancer	0.000839	0.00183	CcSEcCtD
Rufinamide—Haematuria—Methotrexate—urinary bladder cancer	0.000825	0.0018	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—urinary bladder cancer	0.000822	0.0018	CcSEcCtD
Rufinamide—Somnolence—Etoposide—urinary bladder cancer	0.000819	0.00179	CcSEcCtD
Rufinamide—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000819	0.00179	CcSEcCtD
Rufinamide—Epistaxis—Methotrexate—urinary bladder cancer	0.000816	0.00178	CcSEcCtD
Rufinamide—Vomiting—Thiotepa—urinary bladder cancer	0.000816	0.00178	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—urinary bladder cancer	0.000815	0.00178	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—urinary bladder cancer	0.00081	0.00177	CcSEcCtD
Rufinamide—Infestation—Epirubicin—urinary bladder cancer	0.00081	0.00177	CcSEcCtD
Rufinamide—Rash—Thiotepa—urinary bladder cancer	0.000809	0.00177	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—urinary bladder cancer	0.000808	0.00177	CcSEcCtD
Rufinamide—Dermatitis—Thiotepa—urinary bladder cancer	0.000808	0.00177	CcSEcCtD
Rufinamide—Headache—Thiotepa—urinary bladder cancer	0.000804	0.00176	CcSEcCtD
Rufinamide—Decreased appetite—Etoposide—urinary bladder cancer	0.000801	0.00175	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000796	0.00174	CcSEcCtD
Rufinamide—Fatigue—Etoposide—urinary bladder cancer	0.000794	0.00174	CcSEcCtD
Rufinamide—Constipation—Etoposide—urinary bladder cancer	0.000788	0.00172	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—urinary bladder cancer	0.000786	0.00172	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—urinary bladder cancer	0.000786	0.00172	CcSEcCtD
Rufinamide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000782	0.00171	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000776	0.0017	CcSEcCtD
Rufinamide—Asthenia—Gemcitabine—urinary bladder cancer	0.000774	0.00169	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—urinary bladder cancer	0.000772	0.00169	CcSEcCtD
Rufinamide—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000767	0.00168	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000766	0.00167	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—urinary bladder cancer	0.000764	0.00167	CcSEcCtD
Rufinamide—Pruritus—Gemcitabine—urinary bladder cancer	0.000764	0.00167	CcSEcCtD
Rufinamide—Nausea—Thiotepa—urinary bladder cancer	0.000762	0.00167	CcSEcCtD
Rufinamide—Urethral disorder—Methotrexate—urinary bladder cancer	0.000762	0.00166	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—urinary bladder cancer	0.00076	0.00166	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—urinary bladder cancer	0.00076	0.00166	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—urinary bladder cancer	0.000754	0.00165	CcSEcCtD
Rufinamide—Pruritus—Fluorouracil—urinary bladder cancer	0.000751	0.00164	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000749	0.00164	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—urinary bladder cancer	0.000749	0.00164	CcSEcCtD
Rufinamide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000741	0.00162	CcSEcCtD
Rufinamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000738	0.00161	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—urinary bladder cancer	0.000729	0.00159	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—urinary bladder cancer	0.000726	0.00159	CcSEcCtD
Rufinamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000726	0.00159	CcSEcCtD
Rufinamide—Asthenia—Cisplatin—urinary bladder cancer	0.000722	0.00158	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000721	0.00158	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000718	0.00157	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—urinary bladder cancer	0.000715	0.00156	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—urinary bladder cancer	0.000713	0.00156	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000709	0.00155	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—urinary bladder cancer	0.000707	0.00154	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—urinary bladder cancer	0.000703	0.00154	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—urinary bladder cancer	0.000702	0.00153	CcSEcCtD
Rufinamide—Dizziness—Fluorouracil—urinary bladder cancer	0.000702	0.00153	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.0007	0.00153	CcSEcCtD
Rufinamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000688	0.0015	CcSEcCtD
Rufinamide—Vomiting—Gemcitabine—urinary bladder cancer	0.000686	0.0015	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—urinary bladder cancer	0.000681	0.00149	CcSEcCtD
Rufinamide—Rash—Gemcitabine—urinary bladder cancer	0.00068	0.00149	CcSEcCtD
Rufinamide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00068	0.00149	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—urinary bladder cancer	0.000679	0.00149	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000679	0.00148	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—urinary bladder cancer	0.000676	0.00148	CcSEcCtD
Rufinamide—Headache—Gemcitabine—urinary bladder cancer	0.000676	0.00148	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000675	0.00147	CcSEcCtD
Rufinamide—Vomiting—Fluorouracil—urinary bladder cancer	0.000675	0.00147	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—urinary bladder cancer	0.000674	0.00147	CcSEcCtD
Rufinamide—Rash—Fluorouracil—urinary bladder cancer	0.000669	0.00146	CcSEcCtD
Rufinamide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000668	0.00146	CcSEcCtD
Rufinamide—Headache—Fluorouracil—urinary bladder cancer	0.000665	0.00145	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000664	0.00145	CcSEcCtD
Rufinamide—Asthenia—Etoposide—urinary bladder cancer	0.000661	0.00145	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000659	0.00144	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—urinary bladder cancer	0.000657	0.00144	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000655	0.00143	CcSEcCtD
Rufinamide—Back pain—Methotrexate—urinary bladder cancer	0.000654	0.00143	CcSEcCtD
Rufinamide—Pruritus—Etoposide—urinary bladder cancer	0.000652	0.00142	CcSEcCtD
Rufinamide—Nausea—Gemcitabine—urinary bladder cancer	0.000641	0.0014	CcSEcCtD
Rufinamide—Vomiting—Cisplatin—urinary bladder cancer	0.00064	0.0014	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—urinary bladder cancer	0.000637	0.00139	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—urinary bladder cancer	0.000637	0.00139	CcSEcCtD
Rufinamide—Rash—Cisplatin—urinary bladder cancer	0.000634	0.00139	CcSEcCtD
Rufinamide—Dermatitis—Cisplatin—urinary bladder cancer	0.000634	0.00138	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—urinary bladder cancer	0.000633	0.00138	CcSEcCtD
Rufinamide—Diarrhoea—Etoposide—urinary bladder cancer	0.000631	0.00138	CcSEcCtD
Rufinamide—Nausea—Fluorouracil—urinary bladder cancer	0.00063	0.00138	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—urinary bladder cancer	0.000629	0.00137	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—urinary bladder cancer	0.000625	0.00137	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000624	0.00136	CcSEcCtD
Rufinamide—Back pain—Epirubicin—urinary bladder cancer	0.000612	0.00134	CcSEcCtD
Rufinamide—Dizziness—Etoposide—urinary bladder cancer	0.000609	0.00133	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000608	0.00133	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—urinary bladder cancer	0.000608	0.00133	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000606	0.00133	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—urinary bladder cancer	0.000605	0.00132	CcSEcCtD
Rufinamide—Nausea—Cisplatin—urinary bladder cancer	0.000597	0.00131	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—urinary bladder cancer	0.000597	0.0013	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—urinary bladder cancer	0.000589	0.00129	CcSEcCtD
Rufinamide—Convulsion—Methotrexate—urinary bladder cancer	0.000586	0.00128	CcSEcCtD
Rufinamide—Vomiting—Etoposide—urinary bladder cancer	0.000586	0.00128	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—urinary bladder cancer	0.000586	0.00128	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—urinary bladder cancer	0.000585	0.00128	CcSEcCtD
Rufinamide—Agitation—Epirubicin—urinary bladder cancer	0.000582	0.00127	CcSEcCtD
Rufinamide—Rash—Etoposide—urinary bladder cancer	0.000581	0.00127	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—urinary bladder cancer	0.000581	0.00127	CcSEcCtD
Rufinamide—Headache—Etoposide—urinary bladder cancer	0.000577	0.00126	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000572	0.00125	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—urinary bladder cancer	0.000569	0.00124	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—urinary bladder cancer	0.000567	0.00124	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—urinary bladder cancer	0.000566	0.00124	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000552	0.00121	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—urinary bladder cancer	0.000548	0.0012	CcSEcCtD
Rufinamide—Infection—Methotrexate—urinary bladder cancer	0.000548	0.0012	CcSEcCtD
Rufinamide—Nausea—Etoposide—urinary bladder cancer	0.000547	0.0012	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000541	0.00118	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—urinary bladder cancer	0.000541	0.00118	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00054	0.00118	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—urinary bladder cancer	0.000538	0.00118	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—urinary bladder cancer	0.000537	0.00117	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—urinary bladder cancer	0.000536	0.00117	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000535	0.00117	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—urinary bladder cancer	0.000526	0.00115	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—urinary bladder cancer	0.000526	0.00115	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000524	0.00115	CcSEcCtD
Rufinamide—Infection—Epirubicin—urinary bladder cancer	0.000513	0.00112	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—urinary bladder cancer	0.000507	0.00111	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000507	0.00111	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000506	0.00111	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—urinary bladder cancer	0.000502	0.0011	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—urinary bladder cancer	0.000499	0.00109	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—urinary bladder cancer	0.000497	0.00109	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000495	0.00108	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—urinary bladder cancer	0.000492	0.00108	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—urinary bladder cancer	0.000491	0.00107	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000486	0.00106	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—urinary bladder cancer	0.00048	0.00105	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000477	0.00104	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—urinary bladder cancer	0.000476	0.00104	CcSEcCtD
Rufinamide—Infection—Doxorubicin—urinary bladder cancer	0.000475	0.00104	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000469	0.00102	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000468	0.00102	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—urinary bladder cancer	0.000467	0.00102	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—urinary bladder cancer	0.000464	0.00101	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—urinary bladder cancer	0.000459	0.001	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—urinary bladder cancer	0.000456	0.000996	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000455	0.000994	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000449	0.000981	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000446	0.000975	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—urinary bladder cancer	0.000445	0.000973	CcSEcCtD
Rufinamide—Constipation—Epirubicin—urinary bladder cancer	0.000442	0.000965	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—urinary bladder cancer	0.000432	0.000945	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—urinary bladder cancer	0.000425	0.000929	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000421	0.00092	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000415	0.000908	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000413	0.000902	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—urinary bladder cancer	0.000412	0.000901	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—urinary bladder cancer	0.000409	0.000893	CcSEcCtD
Rufinamide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000407	0.000889	CcSEcCtD
Rufinamide—Asthenia—Methotrexate—urinary bladder cancer	0.000396	0.000866	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—urinary bladder cancer	0.000391	0.000854	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000381	0.000832	CcSEcCtD
Rufinamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000378	0.000825	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—urinary bladder cancer	0.000371	0.00081	CcSEcCtD
Rufinamide—Pruritus—Epirubicin—urinary bladder cancer	0.000365	0.000799	CcSEcCtD
Rufinamide—Dizziness—Methotrexate—urinary bladder cancer	0.000365	0.000798	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000353	0.000772	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000352	0.00077	CcSEcCtD
Rufinamide—Vomiting—Methotrexate—urinary bladder cancer	0.000351	0.000767	CcSEcCtD
Rufinamide—Rash—Methotrexate—urinary bladder cancer	0.000348	0.000761	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—urinary bladder cancer	0.000348	0.00076	CcSEcCtD
Rufinamide—Headache—Methotrexate—urinary bladder cancer	0.000346	0.000756	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—urinary bladder cancer	0.000343	0.000749	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—urinary bladder cancer	0.000342	0.000747	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000338	0.000739	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—urinary bladder cancer	0.000328	0.000718	CcSEcCtD
Rufinamide—Nausea—Methotrexate—urinary bladder cancer	0.000328	0.000717	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000327	0.000715	CcSEcCtD
Rufinamide—Rash—Epirubicin—urinary bladder cancer	0.000326	0.000712	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—urinary bladder cancer	0.000325	0.000711	CcSEcCtD
Rufinamide—Headache—Epirubicin—urinary bladder cancer	0.000324	0.000707	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000316	0.000691	CcSEcCtD
Rufinamide—Nausea—Epirubicin—urinary bladder cancer	0.000307	0.000671	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—urinary bladder cancer	0.000304	0.000664	CcSEcCtD
Rufinamide—Rash—Doxorubicin—urinary bladder cancer	0.000301	0.000659	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000301	0.000658	CcSEcCtD
Rufinamide—Headache—Doxorubicin—urinary bladder cancer	0.000299	0.000654	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—urinary bladder cancer	0.000284	0.00062	CcSEcCtD
Rufinamide—SCN4A—Axon guidance—SRC—urinary bladder cancer	0.0002	0.000895	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EP300—urinary bladder cancer	0.000197	0.000884	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TNF—urinary bladder cancer	0.000196	0.00088	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000196	0.000879	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—ERBB2—urinary bladder cancer	0.000196	0.000879	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—KRAS—urinary bladder cancer	0.000195	0.000873	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—RHOA—urinary bladder cancer	0.000195	0.000873	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—RHOA—urinary bladder cancer	0.000195	0.000873	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—SRC—urinary bladder cancer	0.000193	0.000863	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—SRC—urinary bladder cancer	0.000193	0.000863	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NCOR1—urinary bladder cancer	0.000193	0.000863	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—SRC—urinary bladder cancer	0.000192	0.000859	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—EGFR—urinary bladder cancer	0.000191	0.000854	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—HRAS—urinary bladder cancer	0.000189	0.000848	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—RHOA—urinary bladder cancer	0.000188	0.000841	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—RHOA—urinary bladder cancer	0.000188	0.000841	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—ERBB2—urinary bladder cancer	0.000188	0.000841	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—IL2—urinary bladder cancer	0.000188	0.00084	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.000187	0.000839	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—RHOA—urinary bladder cancer	0.000185	0.000829	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EGFR—urinary bladder cancer	0.000184	0.000824	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—EGFR—urinary bladder cancer	0.000182	0.000817	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000181	0.000813	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—ERBB2—urinary bladder cancer	0.00018	0.000808	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—ERBB2—urinary bladder cancer	0.00018	0.000808	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—KRAS—urinary bladder cancer	0.00018	0.000807	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000179	0.000803	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000178	0.000799	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—EGFR—urinary bladder cancer	0.000175	0.000785	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—EGFR—urinary bladder cancer	0.000175	0.000785	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TNF—urinary bladder cancer	0.000175	0.000784	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—ERBB2—urinary bladder cancer	0.000174	0.000779	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—ERBB2—urinary bladder cancer	0.000174	0.000779	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—KRAS—urinary bladder cancer	0.000174	0.000778	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—KRAS—urinary bladder cancer	0.000172	0.000771	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—ERBB2—urinary bladder cancer	0.000171	0.000767	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL2—urinary bladder cancer	0.00017	0.000763	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TERT—urinary bladder cancer	0.00017	0.00076	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—EGFR—urinary bladder cancer	0.000169	0.000757	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—EGFR—urinary bladder cancer	0.000169	0.000757	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MMP9—urinary bladder cancer	0.000168	0.000754	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EGFR—urinary bladder cancer	0.000168	0.000753	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CDK4—urinary bladder cancer	0.000167	0.000749	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—HRAS—urinary bladder cancer	0.000166	0.000742	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—KRAS—urinary bladder cancer	0.000165	0.000741	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—KRAS—urinary bladder cancer	0.000165	0.000741	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000162	0.000728	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MMP9—urinary bladder cancer	0.000161	0.000721	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—urinary bladder cancer	0.00016	0.000717	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EP300—urinary bladder cancer	0.00016	0.000715	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—KRAS—urinary bladder cancer	0.00016	0.000715	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—KRAS—urinary bladder cancer	0.00016	0.000715	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—KRAS—urinary bladder cancer	0.000159	0.000712	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000158	0.000706	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGFR3—urinary bladder cancer	0.000156	0.000698	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—SRC—urinary bladder cancer	0.000155	0.000695	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MMP9—urinary bladder cancer	0.000155	0.000693	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MMP9—urinary bladder cancer	0.000155	0.000693	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—HRAS—urinary bladder cancer	0.000153	0.000686	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EP300—urinary bladder cancer	0.000153	0.000684	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—urinary bladder cancer	0.000152	0.000682	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PPARG—urinary bladder cancer	0.000152	0.000681	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ESR1—urinary bladder cancer	0.000151	0.000678	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP9—urinary bladder cancer	0.000149	0.000668	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP9—urinary bladder cancer	0.000149	0.000668	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—SRC—urinary bladder cancer	0.000148	0.000665	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000148	0.000662	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HRAS—urinary bladder cancer	0.000148	0.000661	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP9—urinary bladder cancer	0.000147	0.000658	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EP300—urinary bladder cancer	0.000147	0.000657	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EP300—urinary bladder cancer	0.000147	0.000657	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—HRAS—urinary bladder cancer	0.000146	0.000656	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CREBBP—urinary bladder cancer	0.000146	0.000654	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000144	0.000646	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—SRC—urinary bladder cancer	0.000143	0.000639	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—SRC—urinary bladder cancer	0.000143	0.000639	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EP300—urinary bladder cancer	0.000141	0.000633	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EP300—urinary bladder cancer	0.000141	0.000633	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—HRAS—urinary bladder cancer	0.000141	0.00063	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—HRAS—urinary bladder cancer	0.000141	0.00063	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—SRC—urinary bladder cancer	0.000137	0.000616	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—SRC—urinary bladder cancer	0.000137	0.000616	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000137	0.000613	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000137	0.000613	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—urinary bladder cancer	0.000136	0.000609	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—HRAS—urinary bladder cancer	0.000136	0.000607	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—HRAS—urinary bladder cancer	0.000136	0.000607	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—SRC—urinary bladder cancer	0.000135	0.000607	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HRAS—urinary bladder cancer	0.000135	0.000605	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—urinary bladder cancer	0.000134	0.000601	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CREBBP—urinary bladder cancer	0.000133	0.000594	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	0.000132	0.000591	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF1—urinary bladder cancer	0.000131	0.000587	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—urinary bladder cancer	0.00013	0.000584	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—urinary bladder cancer	0.00013	0.000583	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—urinary bladder cancer	0.00013	0.00058	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—KRAS—urinary bladder cancer	0.000128	0.000576	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	0.000125	0.00056	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—urinary bladder cancer	0.000125	0.00056	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—urinary bladder cancer	0.000125	0.00056	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTZ1—urinary bladder cancer	0.000124	0.000555	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—urinary bladder cancer	0.000124	0.000555	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—KRAS—urinary bladder cancer	0.000123	0.000551	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—KRAS—urinary bladder cancer	0.000123	0.000551	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	0.000122	0.000548	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.000121	0.000542	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—urinary bladder cancer	0.000121	0.00054	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—urinary bladder cancer	0.000121	0.00054	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—RHOA—urinary bladder cancer	0.00012	0.000537	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—urinary bladder cancer	0.000119	0.000533	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—urinary bladder cancer	0.000119	0.000533	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—urinary bladder cancer	0.000119	0.000532	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—urinary bladder cancer	0.000118	0.000529	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—urinary bladder cancer	0.000118	0.000529	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTO2—urinary bladder cancer	0.000118	0.000526	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NAT1—urinary bladder cancer	0.000118	0.000526	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000116	0.000518	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—urinary bladder cancer	0.000115	0.000514	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—urinary bladder cancer	0.000115	0.000514	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—urinary bladder cancer	0.000114	0.00051	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—urinary bladder cancer	0.000114	0.00051	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	0.000113	0.000504	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—urinary bladder cancer	0.000112	0.000502	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ERBB2—urinary bladder cancer	0.000111	0.000497	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000109	0.000489	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—urinary bladder cancer	0.000109	0.000489	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000108	0.000483	CbGpPWpGaD
Rufinamide—ALB—Metabolism—UGT2B7—urinary bladder cancer	0.000107	0.000482	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	0.000106	0.000476	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL8—urinary bladder cancer	0.000105	0.000472	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	0.000105	0.00047	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—urinary bladder cancer	0.000105	0.000469	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—urinary bladder cancer	0.000104	0.000468	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	0.000104	0.000464	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.000103	0.000463	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2—urinary bladder cancer	0.000101	0.000451	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.0001	0.00045	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—urinary bladder cancer	0.0001	0.00045	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—urinary bladder cancer	0.0001	0.00045	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.99e-05	0.000447	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EP300—urinary bladder cancer	9.94e-05	0.000445	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.9e-05	0.000444	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—urinary bladder cancer	9.81e-05	0.000439	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP4B1—urinary bladder cancer	9.68e-05	0.000434	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—urinary bladder cancer	9.68e-05	0.000433	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—urinary bladder cancer	9.68e-05	0.000433	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SRC—urinary bladder cancer	9.67e-05	0.000433	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—urinary bladder cancer	9.53e-05	0.000427	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—urinary bladder cancer	9.52e-05	0.000427	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1A—urinary bladder cancer	9.49e-05	0.000425	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	9.48e-05	0.000425	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—urinary bladder cancer	9.47e-05	0.000424	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNA2—urinary bladder cancer	9.22e-05	0.000413	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC19A1—urinary bladder cancer	9.14e-05	0.000409	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EP300—urinary bladder cancer	9.03e-05	0.000405	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PRSS3—urinary bladder cancer	8.91e-05	0.000399	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SRC—urinary bladder cancer	8.78e-05	0.000393	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	8.47e-05	0.00038	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMP—urinary bladder cancer	8.28e-05	0.000371	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—urinary bladder cancer	8.07e-05	0.000361	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	8e-05	0.000359	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	7.95e-05	0.000356	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—urinary bladder cancer	7.87e-05	0.000353	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—urinary bladder cancer	7.7e-05	0.000345	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NAT2—urinary bladder cancer	7.49e-05	0.000336	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—urinary bladder cancer	7.27e-05	0.000326	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.14e-05	0.00032	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMP—urinary bladder cancer	7.12e-05	0.000319	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	6.94e-05	0.000311	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.84e-05	0.000306	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	6.8e-05	0.000305	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.69e-05	0.0003	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAU—urinary bladder cancer	6.55e-05	0.000293	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RRM2—urinary bladder cancer	6.47e-05	0.00029	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—urinary bladder cancer	6.46e-05	0.00029	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NAT2—urinary bladder cancer	6.44e-05	0.000288	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.34e-05	0.000284	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.34e-05	0.000284	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—urinary bladder cancer	6.18e-05	0.000277	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO2—urinary bladder cancer	5.99e-05	0.000268	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	5.99e-05	0.000268	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	5.81e-05	0.00026	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.8e-05	0.00026	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RRM2—urinary bladder cancer	5.56e-05	0.000249	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CREBBP—urinary bladder cancer	5.4e-05	0.000242	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—urinary bladder cancer	5.33e-05	0.000239	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.22e-05	0.000234	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO2—urinary bladder cancer	5.15e-05	0.000231	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HPGDS—urinary bladder cancer	5.15e-05	0.000231	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.12e-05	0.000229	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTT1—urinary bladder cancer	4.99e-05	0.000224	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.93e-05	0.000221	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.92e-05	0.00022	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RHOA—urinary bladder cancer	4.89e-05	0.000219	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NQO1—urinary bladder cancer	4.83e-05	0.000216	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.81e-05	0.000215	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.67e-05	0.000209	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NQO1—urinary bladder cancer	4.15e-05	0.000186	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—urinary bladder cancer	4.1e-05	0.000184	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	4.03e-05	0.00018	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.03e-05	0.00018	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.84e-05	0.000172	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMS—urinary bladder cancer	3.74e-05	0.000168	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	3.7e-05	0.000166	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	3.7e-05	0.000166	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EP300—urinary bladder cancer	3.68e-05	0.000165	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—urinary bladder cancer	3.58e-05	0.00016	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.54e-05	0.000159	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.51e-05	0.000157	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	3.48e-05	0.000156	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.48e-05	0.000156	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTP1—urinary bladder cancer	3.46e-05	0.000155	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.35e-05	0.00015	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	3.27e-05	0.000147	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMS—urinary bladder cancer	3.22e-05	0.000144	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOR1—urinary bladder cancer	3.18e-05	0.000142	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—urinary bladder cancer	3.18e-05	0.000142	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX1—urinary bladder cancer	3.05e-05	0.000136	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3e-05	0.000134	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ERCC2—urinary bladder cancer	2.99e-05	0.000134	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—urinary bladder cancer	2.96e-05	0.000133	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—urinary bladder cancer	2.81e-05	0.000126	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.78e-05	0.000124	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.78e-05	0.000124	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.7e-05	0.000121	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.65e-05	0.000119	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—urinary bladder cancer	2.63e-05	0.000118	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.55e-05	0.000114	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—urinary bladder cancer	2.52e-05	0.000113	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—urinary bladder cancer	2.28e-05	0.000102	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.24e-05	0.0001	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CREBBP—urinary bladder cancer	2.19e-05	9.81e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	2.09e-05	9.35e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.87e-05	8.37e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.82e-05	8.15e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—urinary bladder cancer	1.79e-05	8.03e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.74e-05	7.78e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.73e-05	7.77e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.72e-05	7.69e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.72e-05	7.69e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.64e-05	7.37e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.61e-05	7.23e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—urinary bladder cancer	1.56e-05	7e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.52e-05	6.8e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—EP300—urinary bladder cancer	1.49e-05	6.68e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.23e-05	5.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.18e-05	5.29e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.68e-06	4.34e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.44e-06	3.78e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.05e-06	3.61e-05	CbGpPWpGaD
